In Vitro Generated Equine Hepatic-Like Progenitor Cells as a Novel Potent Cell Pool for Equine Metabolic Syndrome (EMS) Treatment
Authors: K. Marycz, Nabila Bourebaba, Anna Serwotka-Suszczak, M. Mularczyk, L. Galuppo, Lynda Bourebaba
Journal: Stem Cell Reviews and Reports
Summary
# Editorial Summary Equine metabolic syndrome (EMS) represents a significant clinical challenge in equine medicine, characterised by insulin resistance and hepatic dysfunction that current therapeutic approaches often fail to adequately address. Researchers differentiated equine adipose-derived stem cells (Eq_ASCs) in vitro to generate hepatic progenitor-like cells (Eq_HPCs), characterising their morphology, gene expression profiles and functional markers through molecular and immunological analysis. The induced Eq_HPCs exhibited characteristic hepatic morphology and downregulated mesenchymal markers (CD105, CD90), whilst simultaneously expressing mature hepatic genes (PECAM-1, ALB, HNF4A) and retaining pluripotency markers (NANOG, SOX-2, OCT-4) at elevated levels. These findings suggest that engineered hepatic progenitors derived from accessible adipose tissue could provide a regenerative cell pool for restoring impaired liver function in EMS horses, potentially circumventing the limitations of pharmacological interventions alone. For practitioners, this work opens a prospective avenue for cell-based therapeutics that might complement existing management strategies, though translation to clinical application will require further safety and efficacy validation in vivo.
Read the full abstract on PubMed
Practical Takeaways
- •This represents early-stage research; clinical application for EMS treatment is not yet available but may offer future therapeutic potential for addressing liver dysfunction in metabolic syndrome
- •EMS management remains multifactorial and requires comprehensive approaches beyond potential future cell-based interventions, including diet, exercise, and veterinary monitoring
- •Practitioners should remain updated on stem cell therapy developments, though current standard EMS management protocols should continue to be followed
Key Findings
- •In vitro differentiation of equine adipose-derived stem cells (Eq_ASCs) successfully generated hepatic progenitor-like cells (Eq_HPCs) with characteristic morphology and gene expression profiles
- •Generated Eq_HPCs displayed downregulated mesenchymal markers (CD105, CD90) and upregulated hepatic lineage genes (PECAM-1, ALB, AFP, HNF4A)
- •Eq_HPCs retained high stemness and pluripotency markers (NANOG, SOX-2, OCT-4), indicating preserved differentiation capacity
- •Cell-based therapy using these hepatic progenitor cells may offer a novel approach to restore liver function in EMS-affected horses